The effect of EGb-761 on morphologic vasospasm in canine basilar artery after subarachnoid hemorrhage

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 3, 2003, Pages 395-402

  Bayar, M Akif ^a,c   Erdem, Yavuz ^a   Öztürk, Koray ^a   Beşcalti, Ömer ^b   Çaydere, Muzaffer ^a   Yücel, Doǧan ^a   Buharali, Zeki ^a   Üstün, Hüseyin ^a  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Gençlik Caddesi ^*  (Turkey)

Author keywords

Endothelin; Ginkgo biloba; Platelet activating factor antagonist; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ENDOTHELIN 1; GINKGO BILOBA EXTRACT; SODIUM CHLORIDE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; EXPERIMENTAL MODEL; HISTOPATHOLOGY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RADIOIMMUNOASSAY; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ANIMALS; BASILAR ARTERY; DOGS; ENDOTHELIN-1; GINKGO BILOBA; MALE; PLANT EXTRACTS; PLATELET ACTIVATING FACTOR; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 0042839689     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200309000-00011     Document Type: Article

References (38)

1. Kassell NF, Torner JC, Haley EC, et al. The international cooperative study on the timing of aneurysms surgery: Part 1-overall management results. J Neurosurg. 1990;73:18-36.
2. Liszczak TM, Varsos VG, Black PM, et al. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg. 1983;58:18-26.
3. Foley PL, Caner H, Kassell NF, et al. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery. 1994;34:108-113.
4. Kochaneck PM, Melick JA, Schoettle RJ, et al. Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain. Stroke. 1990;21:459-462.
5. Lamant V, Mauco G, Braquet P, et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from ginkgo biloba. Biochem Pharmacal. 1987;36:2749-2752.
6. Mc Donald RL, Weir BK. Cerebral vasospasm and free radicals. Free Radic Biol Med. 1994;16:633-643.
7. 2 production by isolated gastric mucosal cells. Am J Physiol. 1989;256:925-930.
8. Lindsberg PJ, Paakkari IA, Hallenbeck JM. Effect of systemic PAF-acether on the spinal cord microcirculation. J Lipid Mediat. 1990;2: 41-56.
9. Ayajiki K, Okamura T, Toda N. Involvement of nitric oxide in endothelium-dependent phasic relaxation caused by histamine in monkey cerebral arteries. Jpn J Physiol. 1992;60:357-362.
10. Bauknight GC, Faraci FH, Heistad DD. Endothelium-derived relaxing factor modulates noradrenergic constriction of cerebral arterioles in rabbits. Stroke. 1992;23:1522-1526.
11. Braquet P, Hasford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol. 1991;32: 135-139.
12. Delaflotte S, Auguet M, De Feudis FV, et al. Endothelium-dependent relaxation of rabbit isolated aorta produced by carbachol and by Ginkgo biloba extract. Biomed Biochim Acta. 1984;43:5212-5216.
13. Etienne A, Hecquet F, Clostre F, et al. Mechanism of effect of Ginkgo biloba on experimental cerebral edema. In: Fünfgeld EW, ed. Rokan (Ginkgo Biloba) Recent Results in Pharmacology and Clinic. New York: Springer; 1998:133-142.
14. Kurtsoy A, Canbay S, Öktem IS, et al. Effect of EGb-761 on vasospasm in experimental subarachnoid hemorrhage. Res Exp Med. 2000;199: 207-215.
15. Lee Poncin -Lafitte M, Rapin J, Rapin JR. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn Ther. 1980;243:236-244.
16. Oyama Y, Ueha T, Hayashi A, et al. Flow cytometric estimation of the effect of Ginkgo biloba extract on the content of hydrogen peroxide in dissociated mammalian brain neuron. Jpn Pharmacol. 1992;60:385-388.
17. Pincemail J, Deby C. The antiradical properties of Ginkgo biloba extract. In: Fünfgeld EW, ed. Rökan (Ginkgo Biloba). Recent Results in Pharmacology and Clinic. New York: Springer; 1988:71-80.
18. Mayberg MR, Okada T, Bark DH. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg. 1990;72:626-633.
19. Varsos VG, Liszczok TM, Han DH, et al. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a " two-hemorrhage" canine model. J Neurosurg. 1983;58:11-17.
20. Faraci FM, Lopez JAG, Breese KR, et al. Effect of atherosclerosis on cerebral vascular response to activation of leucocytes and platelets in monkeys. Stroke. 1991;22:790-796.
21. 2 following total global cerebral ischemia. J Neurosurg. 1988;69:416-420.
22. Heistad DD, Breese K, Armstrong ML, et al. Cerebral vasoconstrictor responses to serotonin after dietary treatment for transient ischemic stroke. Stroke. 1987;18:1068-1073.
23. Faraci FM, Heistad DD. Endothelium-derived relaxing factor inhibits constrictor response of large cerebral arteries to serotonin. J Cereb Blood Flow Metab. 1992;12:500-506.
24. 4 following subarachnoid hemorrhage. J Neurosurg. 1988;69:488-493.
25. Cosentino F, Mc Mahon EG, Carter CS, et al. Effect of endothelin-A-Receptor Antagonist Bq-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol. 1993;22(Suppl 8):332-335.
26. Matsumara Y, Ikegawa R, Suzuki Y, et al. Phosphoramidon prevent cerebral vasospasm following subarachnoid hemorrhage in dogs. The relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci. 1991; 49:841-848.
27. Gaetani P, Baena RR, Grignani G, et al. Endothelin and aneurysmal subarachnoid hemorrhage a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1994;57:66-72.
28. Wanebo JE, Arthur AS, Louis HG, et al. Systemic administration of the endothelin A receptor antagonist TBC 11251 attenuates. Cerebral vasospasm after experimental subarachnoid hemorrhage: Dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery. 1998;43:1409-1418.
29. Mc Donald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
30. Gaetani P, Marzatico F, Lombardi D, et al. Effect of high-dose methylprednisolone and U 74006 F on eicosanoid synthesis after subarachnoid hemorrhage in rats. Stroke. 1991;22:215-220.
31. Toda N, Ayajiki K, Okamura T, et al. Endothelial modulation of contractions caused by oxyhemoglobin and NG-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke. 1993;24:1584-1589.
32. Hirashima Y, Endo S, Otsuji T, et al. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg. 1993; 78:592-597.
33. Peterson JW, Kwun BD, Hackett JD. The role of inflammation in experimental cerebral vasospasm. J Neurosurg. 1990;72:767-774.
34. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage an update. Ann Neurol. 1983;14:599-608.
35. Tanabe Y, Sakata K, Yamada H, et al. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study. J Neurosurg. 1978;49:229-238.
36. Egan RW, Paxton J, Kuehr FA Jr. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem. 1976;251: 7329-7335.
37. Fuerstein G, Yue TL, Lysko PG. Platelet -activating factor. Aputative mediator in central nervous system injury? Stroke. 1990;21 (Suppl 11): 90-94.
38. Braquet P, Spinnewyn B, Braquet M, et al. 52021 and related compounds: a new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba. Blood Vessels. 1985;16:558-572.